Department of Biomedical Sciences, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Division of Rheumatology, Children's Hospital of Philadelphia (CHOP), Philadelphia Pennsylvania, USA.
JCI Insight. 2019 Apr 4;4(7). doi: 10.1172/jci.insight.126751.
Systemic lupus erythematosus (SLE) is an autoimmune disorder that predominantly affects women and is driven by autoreactive T cell-mediated inflammation. It is known that individuals with multiple X-chromosomes are at increased risk for developing SLE; however, the mechanisms underlying this genetic basis are unclear. Here, we use single cell imaging to determine the epigenetic features of the inactive X (Xi) in developing thymocytes, mature T cell subsets, and T cells from SLE patients and mice. We show that Xist RNA and heterochromatin modifications transiently reappear at the Xi and are missing in mature single positive T cells. Activation of mature T cells restores Xist RNA and heterochromatin marks simultaneously back to the Xi. Notably, X-chromosome inactivation (XCI) maintenance is altered in T cells of SLE patients and late-stage-disease NZB/W F1 female mice, and we show that X-linked genes are abnormally upregulated in SLE patient T cells. SLE T cells also have altered expression of XIST RNA interactome genes, accounting for perturbations of Xi epigenetic features. Thus, abnormal XCI maintenance is a feature of SLE disease, and we propose that Xist RNA localization at the Xi could be an important factor for maintaining dosage compensation of X-linked genes in T cells.
系统性红斑狼疮(SLE)是一种自身免疫性疾病,主要影响女性,由自身反应性 T 细胞介导的炎症驱动。已知具有多个 X 染色体的个体患 SLE 的风险增加;然而,这种遗传基础的机制尚不清楚。在这里,我们使用单细胞成像来确定发育中的胸腺细胞、成熟 T 细胞亚群和来自 SLE 患者和小鼠的 T 细胞中失活 X(Xi)的表观遗传特征。我们表明,Xist RNA 和异染色质修饰在 Xi 上短暂重新出现,并在成熟的单阳性 T 细胞中缺失。成熟 T 细胞的激活同时将 Xist RNA 和异染色质标记恢复到 Xi。值得注意的是,SLE 患者和晚期疾病 NZB/W F1 雌性小鼠的 T 细胞中 X 染色体失活(XCI)维持发生改变,我们表明 SLE 患者 T 细胞中的 X 连锁基因异常上调。SLE T 细胞还表现出 XIST RNA 相互作用基因的异常表达,这解释了 Xi 表观遗传特征的扰动。因此,异常的 XCI 维持是 SLE 疾病的一个特征,我们提出 Xi 上的 Xist RNA 定位可能是维持 T 细胞中 X 连锁基因剂量补偿的一个重要因素。